407 related articles for article (PubMed ID: 29652170)
21. SP-D counteracts GM-CSF-mediated increase of granuloma formation by alveolar macrophages in lysinuric protein intolerance.
Douda DN; Farmakovski N; Dell S; Grasemann H; Palaniyar N
Orphanet J Rare Dis; 2009 Dec; 4():29. PubMed ID: 20030831
[TBL] [Abstract][Full Text] [Related]
22. Pulmonary alveolar proteinosis, a primary immunodeficiency of impaired GM-CSF stimulation of macrophages.
Trapnell BC; Carey BC; Uchida K; Suzuki T
Curr Opin Immunol; 2009 Oct; 21(5):514-21. PubMed ID: 19796925
[TBL] [Abstract][Full Text] [Related]
23. Gene therapy of beta(c)-deficient pulmonary alveolar proteinosis (beta(c)-PAP): studies in a murine in vivo model.
Kleff V; Sorg UR; Bury C; Suzuki T; Rattmann I; Jerabek-Willemsen M; Poremba C; Flasshove M; Opalka B; Trapnell B; Dirksen U; Moritz T
Mol Ther; 2008 Apr; 16(4):757-64. PubMed ID: 18334984
[TBL] [Abstract][Full Text] [Related]
24. Pulmonary Alveolar Proteinosis Syndrome.
Suzuki T; Trapnell BC
Clin Chest Med; 2016 Sep; 37(3):431-40. PubMed ID: 27514590
[TBL] [Abstract][Full Text] [Related]
25. Pulmonary alveolar proteinosis is a disease of decreased availability of GM-CSF rather than an intrinsic cellular defect.
Thomassen MJ; Yi T; Raychaudhuri B; Malur A; Kavuru MS
Clin Immunol; 2000 May; 95(2):85-92. PubMed ID: 10779401
[TBL] [Abstract][Full Text] [Related]
26. Alveolar proteinosis syndrome: pathogenesis, diagnosis, and management.
Huizar I; Kavuru MS
Curr Opin Pulm Med; 2009 Sep; 15(5):491-8. PubMed ID: 19561506
[TBL] [Abstract][Full Text] [Related]
27. Peroxisome proliferator-activated receptor-gamma is deficient in alveolar macrophages from patients with alveolar proteinosis.
Bonfield TL; Farver CF; Barna BP; Malur A; Abraham S; Raychaudhuri B; Kavuru MS; Thomassen MJ
Am J Respir Cell Mol Biol; 2003 Dec; 29(6):677-82. PubMed ID: 12805087
[TBL] [Abstract][Full Text] [Related]
28. Elevated gelatinase activity in pulmonary alveolar proteinosis: role of macrophage-colony stimulating factor.
Bonfield TL; Swaisgood CM; Barna BP; Farver CF; Kavuru MS; Thomassen MJ
J Leukoc Biol; 2006 Jan; 79(1):133-9. PubMed ID: 16275889
[TBL] [Abstract][Full Text] [Related]
29. Patient-derived granulocyte/macrophage colony-stimulating factor autoantibodies reproduce pulmonary alveolar proteinosis in nonhuman primates.
Sakagami T; Beck D; Uchida K; Suzuki T; Carey BC; Nakata K; Keller G; Wood RE; Wert SE; Ikegami M; Whitsett JA; Luisetti M; Davies S; Krischer JP; Brody A; Ryckman F; Trapnell BC
Am J Respir Crit Care Med; 2010 Jul; 182(1):49-61. PubMed ID: 20224064
[TBL] [Abstract][Full Text] [Related]
30. Alveolar macrophages in pulmonary alveolar proteinosis: origin, function, and therapeutic strategies.
Huang X; Cao M; Xiao Y
Front Immunol; 2023; 14():1195988. PubMed ID: 37388737
[TBL] [Abstract][Full Text] [Related]
31. Immune dysregulation in the pathogenesis of pulmonary alveolar proteinosis.
Martinez-Moczygemba M; Huston DP
Curr Allergy Asthma Rep; 2010 Sep; 10(5):320-5. PubMed ID: 20623372
[TBL] [Abstract][Full Text] [Related]
32. Hepatic Steatosis Accompanies Pulmonary Alveolar Proteinosis.
Hunt AN; Malur A; Monfort T; Lagoudakis P; Mahajan S; Postle AD; Thomassen MJ
Am J Respir Cell Mol Biol; 2017 Oct; 57(4):448-458. PubMed ID: 28489415
[TBL] [Abstract][Full Text] [Related]
33. Pulmonary alveolar proteinosis - current and future therapeutical strategies.
Jehn LB; Bonella F
Curr Opin Pulm Med; 2023 Sep; 29(5):465-474. PubMed ID: 37395514
[TBL] [Abstract][Full Text] [Related]
34. The molecular basis of pulmonary alveolar proteinosis.
Carey B; Trapnell BC
Clin Immunol; 2010 May; 135(2):223-35. PubMed ID: 20338813
[TBL] [Abstract][Full Text] [Related]
35. Targeting cholesterol homeostasis in lung diseases.
Sallese A; Suzuki T; McCarthy C; Bridges J; Filuta A; Arumugam P; Shima K; Ma Y; Wessendarp M; Black D; Chalk C; Carey B; Trapnell BC
Sci Rep; 2017 Aug; 7(1):10211. PubMed ID: 28860566
[TBL] [Abstract][Full Text] [Related]
36. Granulocyte-macrophage colony-stimulating factor and pulmonary surfactant homeostasis.
Reed JA; Whitsett JA
Proc Assoc Am Physicians; 1998; 110(4):321-32. PubMed ID: 9686680
[TBL] [Abstract][Full Text] [Related]
37. BAL findings in a patient with pulmonary alveolar proteinosis successfully treated with GM-CSF.
Schoch OD; Schanz U; Koller M; Nakata K; Seymour JF; Russi EW; Boehler A
Thorax; 2002 Mar; 57(3):277-80. PubMed ID: 11867836
[TBL] [Abstract][Full Text] [Related]
38. Effective hematopoietic stem cell-based gene therapy in a murine model of hereditary pulmonary alveolar proteinosis.
Hetzel M; Lopez-Rodriguez E; Mucci A; Nguyen AHH; Suzuki T; Shima K; Buchegger T; Dettmer S; Rodt T; Bankstahl JP; Malik P; Knudsen L; Schambach A; Hansen G; Trapnell BC; Lachmann N; Moritz T
Haematologica; 2020 Apr; 105(4):1147-1157. PubMed ID: 31289207
[TBL] [Abstract][Full Text] [Related]
39. Elderly-onset hereditary pulmonary alveolar proteinosis and its cytokine profile.
Ito M; Nakagome K; Ohta H; Akasaka K; Uchida Y; Hashimoto A; Shiono A; Takada T; Nagata M; Tohyama J; Hagiwara K; Kanazawa M; Nakata K; Tazawa R
BMC Pulm Med; 2017 Feb; 17(1):40. PubMed ID: 28212655
[TBL] [Abstract][Full Text] [Related]
40. Aerosolized GM-CSF ameliorates pulmonary alveolar proteinosis in GM-CSF-deficient mice.
Reed JA; Ikegami M; Cianciolo ER; Lu W; Cho PS; Hull W; Jobe AH; Whitsett JA
Am J Physiol; 1999 Apr; 276(4):L556-63. PubMed ID: 10198353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
